Co-Diagnostics, Inc. Lease, Cost
Co-Diagnostics, Inc. (CODX) reported Lease, Cost of $267.27 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-13
- Co-Diagnostics, Inc. lease, cost for the quarter ending 2026-06-30 was $267.27K, a 3.54% increase year-over-year.
- Co-Diagnostics, Inc. lease, cost for the quarter ending 2026-03-31 was $261.69K, a 1.40% increase year-over-year.
- Co-Diagnostics, Inc. lease, cost for the quarter ending 2025-12-31 was $261.67K, a 1.54% decline year-over-year.
- Co-Diagnostics, Inc. lease, cost for the quarter ending 2025-09-30 was $259.64K, a 2.53% decline year-over-year.
- Co-Diagnostics, Inc. lease, cost for fiscal 2025 was $1.04M, a 3.38% decline from fiscal 2024.
- Co-Diagnostics, Inc. lease, cost for fiscal 2024 was $1.07M, a 6.11% increase from fiscal 2023.
- Co-Diagnostics, Inc. lease, cost for fiscal 2023 was $1.01M, a 38.39% increase from fiscal 2022.
- Co-Diagnostics, Inc. lease, cost for fiscal 2022 was $731.25K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $267.27K 10-Q · filed 2026-08-13 | $528.95K 10-Q · filed 2026-08-13 | $790.62K derived: sum of 3 quarters · filed 2026-08-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $261.69K 10-Q · filed 2026-05-14 | $523.35K derived: sum of 2 quarters · filed 2026-05-14 | $783.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $261.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $521.31K derived: sum of 2 quarters · filed 2026-03-31 | $779.43K derived: sum of 3 quarters · filed 2026-08-13 | $1.04M 10-K · filed 2026-03-31 |
| 2025-09-30 | $259.64K 10-Q · filed 2025-11-13 | $517.76K derived: sum of 2 quarters · filed 2026-08-13 | $775.83K 10-Q · filed 2025-11-13 | $1.04M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $258.12K 10-Q · filed 2026-08-13 | $516.19K 10-Q · filed 2026-08-13 | $781.95K derived: sum of 3 quarters · filed 2026-08-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $258.06K 10-Q · filed 2026-05-14 | $523.83K derived: sum of 2 quarters · filed 2026-05-14 | $790.22K derived: sum of 3 quarters · filed 2026-05-14 | $1.06M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $265.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $532.16K derived: sum of 2 quarters · filed 2026-03-31 | $797.05K derived: sum of 3 quarters · filed 2026-03-31 | $1.07M 10-K · filed 2026-03-31 |
| 2024-09-30 | $266.39K 10-Q · filed 2025-11-13 | $531.29K derived: sum of 2 quarters · filed 2025-11-13 | $808.02K 10-Q · filed 2025-11-13 | $1.10M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $264.90K 10-Q · filed 2025-08-14 | $541.63K 10-Q · filed 2025-08-14 | $832.28K derived: sum of 3 quarters · filed 2025-08-14 | $1.12M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $276.73K 10-Q · filed 2025-05-08 | $567.39K derived: sum of 2 quarters · filed 2025-05-08 | $850.44K derived: sum of 3 quarters · filed 2025-05-08 | $961.59K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $290.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $573.71K derived: sum of 2 quarters · filed 2025-03-27 | $684.85K derived: sum of 3 quarters · filed 2025-03-27 | $1.01M 10-K · filed 2025-03-27 |
| 2023-09-30 | $283.05K 10-Q · filed 2024-11-07 | $394.20K derived: sum of 2 quarters · filed 2024-11-07 | $721.35K 10-Q · filed 2024-11-07 | $790.53K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $111.15K 10-Q · filed 2024-08-08 | $307.43K 10-Q · filed 2024-08-08 | $507.48K derived: sum of 3 quarters · filed 2024-08-08 | $703.57K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $196.28K 10-Q · filed 2023-05-11 | $396.33K derived: sum of 2 quarters · filed 2023-05-11 | $592.42K derived: sum of 3 quarters · filed 2023-05-11 | $764.87K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $200.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $396.14K derived: sum of 2 quarters · filed 2023-03-16 | $568.58K derived: sum of 3 quarters · filed 2023-03-16 | $731.25K 10-K · filed 2023-03-16 |
| 2022-09-30 | $196.09K 10-Q · filed 2022-11-10 | $368.54K derived: sum of 2 quarters · filed 2022-11-10 | $531.20K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $172.44K 10-Q · filed 2022-08-11 | $335.11K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $162.67K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |